RG
GOSS icon

Redmile Group’s Gossamer Bio GOSS Stock Holding History

Redmile Group’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-259,700
Closed -$2.64M – 84
2020
Q1 		$2.64M Sell
259,700
-600
-0.2% -$7.83K 0.07% 62
2019
Q4 		$4.07M Sell
260,300
-200
-0.1% -$4.03K 0.1% 60
2019
Q3 		$4.37M Buy
260,500
+11,900
+5% +$237K 0.15% 59
2019
Q2 		$5.51M Sell
248,600
-1,400
-0.6% -$26.8K 0.16% 63
2019
Q1 		$5.42M Buy
+250,000
New +$5.21M 0.16% 61

Other funds holding GOSS

HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Redmile Group's GOSS Position: Q2 2020 in Review

Redmile Group sold out of Gossamer Bio (GOSS) in Q2 2020, closing a stake of 259,700 shares — an estimated $2.64M sold.

Redmile Group first reported a position in GOSS in Q1 2019 and held it in 5 quarters. The position peaked at $5.51M in Q2 2019. 110 funds tracked by Wall St. Rank hold GOSS as of Q2 2020.

  • Redmile Group reported no remaining Gossamer Bio position as of Q2 2020 after selling out during the quarter.
  • Redmile Group sold 259,700 Gossamer Bio shares in Q2 2020, an estimated $2.64M.
  • Redmile Group first reported a position in Gossamer Bio in Q1 2019 and held it in 5 quarters.
  • Redmile Group's Gossamer Bio position peaked at $5.51M in Q2 2019.
  • 110 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2020.

Based on Redmile Group's 13F filing for Q2 2020, filed 14 Aug 2020.